Changeflow GovPing Healthcare & Life Sciences EP4329880A1 - Small Molecule Modulators of Gluc...
Routine Rule Added Final

EP4329880A1 - Small Molecule Modulators of Glucocerebrosidase Activity

Favicon for changeflow.com EPO Patent Bulletin - Organic Chemistry (C07D)
Published
Detected
Email

Summary

Vanqua Bio, Inc. has obtained publication of European patent application EP4329880A1 titled 'Small Molecule Modulators of Glucocerebrosidase Activity and Uses Thereof,' filed by inventors Kevin Hunt and Jianbin Zheng. The application covers C07D-classified small molecule compounds that modulate glucocerebrosidase activity, with potential neurological applications indicated by the A61P 25/16 classification. The EPO published the application with search report on 15 April 2026, designating all EU member states and extension states.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Organic Chemistry (C07D) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 63 changes logged to date.

Notice an inaccuracy or want this record removed? Email corrections@changeflow.com . We respond within 48 hours and honor reasonable requests. See our editorial standards .

What changed

European patent application EP4329880A1 was published by the EPO on 15 April 2026, covering small molecule modulators of glucocerebrosidase activity and their therapeutic uses. Vanqua Bio, Inc. is named as the applicant with inventors Kevin Hunt and Jianbin Zheng. The application carries IPC classifications C07D 417/14 and C07D 487/04, with an indicated therapeutic application under A61P 25/16 (neurological disorders, potentially Parkinson's disease). The publication designates all EU member states and several extension countries.

Pharmaceutical and biotechnology companies researching glucocerebrosidase-targeted therapies should monitor this filing for potential freedom-to-operate implications, particularly in Parkinson's and Gaucher disease programs. Competitors in the CNS drug discovery space may wish to review the compound claims for overlap with their own development pipelines. The patent is in the published-application stage; grant and national validation remain subject to examination.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF

Publication EP4329880A1 Kind: A1 Apr 15, 2026

Applicants

Vanqua Bio, Inc.

Inventors

HUNT, Kevin, ZHENG, Jianbin

IPC Classifications

C07D 417/14 20060101AFI20250128BHEP C07D 487/04 20060101ALI20250128BHEP A61P 25/16 20060101ALI20250128BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application Drug discovery CNS therapeutics
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!